期刊文献+

超声辐照对HepG_2细胞存活率影响的实验研究 被引量:1

Effect of ultrasound irradiation on viability of HepG_2 cell:an experimental study in vitro
下载PDF
导出
摘要 为探讨超声辐照对体外培养的HepG2细胞存活力的影响,采用正交设计方法,选定声强、占空比和辐照时间3因素,每因素5水平的参数条件设计正交表,对贴壁培养的HepG2细胞进行超声辐照,之后继续培养24 h后行MTT(噻唑蓝)实验检测细胞存活率,期间光学显微镜观察培养板内的细胞生长状况及形态。结果表明:当超声声强大于2 W/cm2任何情况及声强1.5 W/cm2、占空比大于60%时,细胞出现明显脱壁、形态变圆、弹坑样聚集以及脱壁细胞内出现颗粒和细胞碎裂等现象,细胞存活率大大降低。超声声强在0.5~1.0 W/cm2,占空比在10%-20%时,细胞存活率可确保达到90%以上。正交设计统计分析提示超声声强和占空比是影响细胞存活率的主要因素,且声强影响大于占空比(P<0.05),而辐照时间并非主要因素(P>0.05)。 To investigate the effect of ultrasound irradiation on viability of HepG2 cells in vitro,the parameters of acoustic intensity,duty factor and duration of therapeutic ultrasound are selected,and the ultrasound irradiations are performed according to the orthogonal design.After 24 h of ultrasound irradiations,MTT assays are performed to assess the viability of HepG2 cells.The morphologic change of cells are observed using optical micrography before and after ultrasound irradiation.The results show that,when the acoustic intensity is greater than 2 W/cm2 with any duty factor or the acoustic intensity is 1.5 W/cm2 with the duty factor greater than 60%,the viability of HepG2 cells decreases significantly,and the detachment,craterlike aggregation,and cell fragmentation of cells could be observed by optical microscope.When the acoustic intensity ranges from 0.5 to 1.0 W/cm2 and the duty factor is 10%-20%,the rate of cell viability can be more than 90% immovably.The statistical analysis of orthogonal design indicates that the acoustic intensity and duty factor are the most important parameters for the HepG2 cell viability irradiated by therapeutic ultrasound in vitro.
出处 《声学技术》 CSCD 2011年第2期158-160,共3页 Technical Acoustics
基金 上海市重点学科建设资助项目(B112)
关键词 超声 细胞存活率 HEPG2细胞 正交设计 ultrasound Cell viability HepG2 cell orthogonal design
  • 相关文献

参考文献7

  • 1Lawrie A,Brisken A F,Francis S E,et al.Ultrasound enhances re[prter gene expression after transfection of vascular cells in vitro[J].Circulation,1999,99(20):2617-2620.
  • 2Lawrie A,Brisken A F,Francis S E,et al.Microbubble-enhanced ultrasound for vascular gene delivery[J].Gene Ther,2000,7(23):2023-2027.
  • 3LI Y S,Davidson E,Reid C N,et al.Optimizing ultrasound-mediated gene transfer (sonoporation) in vitro and prolonged expression of a transgene in vivo:potential applications for gene therapy of cancer[J].Cancer Lett,2009,273(1):62-69.
  • 4LIANG H D,LU Q L,XUE S A,et al.Optimisation of ultrasound-mediated gene transfer (sonoporation) in skeletal muscle cells[J].Ultrasound Med Biol,2004,30(11):1523-1529.
  • 5Jr Feril L B,Ogawa R,Tachibana K,et al.Optimized ultrasound-mediated gene transfection in cancer cells[J].Cancer Sci,2006,97(10):1111-1114.
  • 6Rahim A,Taylor S L,Bush N L,et al.Physical parameters affecting ultrasound/microbubble-mediated gene delivery efficiency in vitro[J].Ultrasound Med Biol,2006,32(8):1269-1279.
  • 7陈智毅,谢明星,王新房,吕清.治疗性超声介导体外基因转染的参数优化[J].中国医学影像技术,2008,24(10):1511-1514. 被引量:10

二级参考文献13

  • 1张群霞,王志刚,冉海涛,李晓东,郑元义,景香香.不同超声强度及微泡对基因和组织作用的实验研究[J].中华超声影像学杂志,2005,14(4):304-306. 被引量:7
  • 2Kodama T, Tan PH, Offiah I, et al. Delivery of oligodeoxynucleotides into human saphenous veins and the adjunct effect of ultrasound and mierobubbles. Ultrasound Med Biol, 2005, 31 (12) : 1683-1691.
  • 3Li T, Tachibana K, Kuroki M, et al. Gene transfer with echo-enhanced contrast agents: comparison between Albunex, Optison, and Levovist in mice-initial results. Radiology, 2003,229 (2) : 423- 428.
  • 4Nishida K, Doita M, Takada T, et al. Sustained transgene expression in intervertebral disc cells in vivo mediated by microbubble-enhanced ultrasound gene therapy. Spine, 2006,31(13):1415-1419.
  • 5Chen S, Shohet RV, Bekeredjian R, et al. Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by ultrasound-targeted microbubble destruction. J Am Coil Cardiol, 2003,42(2):301-308.
  • 6Rahim AA, Taylor SL, Bush NL, et al. Spatial and aeoustic pressure dependence of microbubble-mediated gene delivery targeted using focused ultrasound. J Gene Med, 2006,8(11):1347-1357.
  • 7Kinoshita M, Hynynen K. A novel method for the intracellular delivery of siRNA using mierobubble-enhanced focused ultrasound. Biochem Biophys Res Commun, 2005 335(2) :393-399.
  • 8Nie Y, Zhang ZR, Duan YR. Combined use of polycationic peptide and biodegradable macromolecular polymer as a novel gene delivery system: a preliminary study. Drug Deliv, 2006, 13 (6): 441-446.
  • 9Kuo JH, Jan MS, Sung KC. Evaluation of the stability of poly mer-based plasmid DNA delivery systems after ultrasound exposure. International Journal of Pharmaceutics, 2003,257 (1-2) : 75- 84.
  • 10Gao X, Kim KS, Liu D. Nonviral gene delivery: what we know and what is next. AAPS J, 2007,9(1) :92-104.

共引文献9

同被引文献8

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部